Sorafenib maintenance after hematopoietic stem cell transplantation improves outcome of FLT3–ITD-mutated acute myeloid leukemia

In a retrospective analysis, 21 acute myeloid leukemia patients receiving single-agent sorafenib maintenance therapy in complete remission (CR) after hematopoietic stem cell transplantation (HSCT) were compared with a control group of 22 patients without maintenance. Sorafenib was initiated a median...

Descripción completa

Detalles Bibliográficos
Autores principales: Aydin, Semra, Passera, Roberto, Scaldaferri, Matilde, Dellacasa, Chiara Maria, Poggiu, Marco, Cattel, Francesco, Zallio, Francesco, Brunello, Lucia, Giaccone, Luisa, Dogliotti, Irene, Busca, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668769/
https://www.ncbi.nlm.nih.gov/pubmed/35943684
http://dx.doi.org/10.1007/s12185-022-03427-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668769/
https://www.ncbi.nlm.nih.gov/pubmed/35943684
http://dx.doi.org/10.1007/s12185-022-03427-4

Ejemplares similares